Scott Gottlieb Announces 3 New FDA Guidances Focused On NGS, In Vitro Diagnostic Development

April 13, 2018 | Yesterday, FDA Commissioner Scott Gottlieb announced via Twitter new policies for the Administration he says are designed to "keep pace with fast-moving [next-generation sequencing] technologies." The three guidances focus solely on NGS and in vitro diagnostic development. Diagnostics World News